Inspire Medical Systems (INSP) Stock Price, News & Analysis

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings or view top-rated stocks.

13 Wall Street analysts have issued twelve-month price targets for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they predict the company's stock price to reach $271.29 in the next year. This suggests a possible upside of 21.6% from the stock's current price.
View analysts price targets for INSP or view top-rated stocks among Wall Street analysts.

Inspire Medical Systems' stock was trading at $203.43 at the start of the year. Since then, INSP shares have increased by 9.7% and is now trading at $223.14.
View the best growth stocks for 2024 here.

Inspire Medical Systems saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,080,000 shares, an increase of 11.2% from the March 15th total of 1,870,000 shares. Based on an average trading volume of 488,200 shares, the short-interest ratio is presently 4.3 days.
View Inspire Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our INSP earnings forecast.

Inspire Medical Systems will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Inspire Medical Systems, Inc. (NYSE:INSP) announced its quarterly earnings results on Tuesday, February, 6th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of ($0.04) by $0.53. The firm earned $192.51 million during the quarter, compared to the consensus estimate of $186.75 million. Inspire Medical Systems had a negative net margin of 3.39% and a negative trailing twelve-month return on equity of 3.93%. The business's quarterly revenue was up 39.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.10 EPS.

ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Harbor Health Care ETF (MEDI), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC), SPDR S&P Health Care Equipment ETF (XHE) and WisdomTree U.S. Growth & Momentum Fund (WGRO).

Inspire Medical Systems issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $775.0 million-$785.0 million, compared to the consensus revenue estimate of $780.3 million.

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

Inspire Medical Systems (INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems' stock is owned by many different institutional and retail investors. Top institutional investors include Rheos Capital Works Inc. (0.26%), Congress Asset Management Co. MA (0.05%), Massmutual Trust Co. FSB ADV (0.05%) and Moody National Bank Trust Division (0.00%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.